Kingsoft Cloud Holdings Limited vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Kingsoft Cloud Holdings Limited trades at $9.26 (market cap $2.71B), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Kingsoft Cloud Holdings Limited is the larger of the two by market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kingsoft Cloud Holdings Limited for 12 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| KC | NUVB | |
|---|---|---|
Market Cap | $2.71B | $1.74B |
Volume | 1,993,765 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $18.21 | $9.54 |
52-Week Low | $8.58 | $3.41 |
Typical Hold Time | 12 Days | 1 Days |
Enterprise Value | $3.03B | $1.33B |
Signals from Pluang's Aura AI — not financial advice
Kingsoft Cloud (KC) trades at $9.26, up 0.27% with bearish technical signals but strong analyst support. The company shows improving fundamentals with Q2 2026 revenue growth of 30.8% year-over-year and three consecutive earnings beats. While still reporting net losses, gross margins improved significantly and AI cloud services are emerging as a key growth driver, with billings surging 82% year-over-year.
KC presents a compelling turnaround story with 70% analyst buy ratings and 60% upside potential, though risks include persistent losses, competitive pressures, and technical weakness. The AI cloud partnership with Xiaomi positions the stock for growth, but investors should weigh the fundamental improvements against the current bearish technical setup.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →